These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32724349)

  • 1. Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer.
    Wang L; Si H; Wang J; Feng L; Zhai W; Dong S; Yu Z
    Oncol Lett; 2020 Aug; 20(2):1101-1110. PubMed ID: 32724349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort.
    Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY
    Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer.
    Feng F; Sun L; Zheng G; Liu S; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
    Oncotarget; 2017 Jan; 8(3):5281-5291. PubMed ID: 28029656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer.
    Zheng L; Xiong A; Wang S; Xu J; Shen Y; Zhong R; Lu J; Chu T; Zhang W; Li Y; Zheng X; Han B; Zhong H; Nie W; Zhang X
    Front Immunol; 2023; 14():1094378. PubMed ID: 36776882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
    Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
    J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
    Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
    Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors.
    Feng F; Tian Y; Liu S; Zheng G; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
    Medicine (Baltimore); 2016 Apr; 95(14):e3248. PubMed ID: 27057867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non-small cell lung cancer.
    Han R; Zhang F; Hong Q; Visar D; Zhan C; Zhao C; Wang F; Zhang S; Li F; Li J; Mu J
    Thorac Cancer; 2024 Aug; 15(24):1792-1804. PubMed ID: 39034535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Ding M; Song Y; Jing J; Tian M; Ding L; Li Q; Zhou C; Dong H; Ni Y; Mou Y
    Front Oncol; 2021; 11():719513. PubMed ID: 34552873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort.
    Jalali A; Miresse D; Fahey MR; Ni Mhaonaigh N; McGuire A; Bourke E; Kerin MJ; Brown JAL
    Curr Oncol; 2022 Oct; 29(10):7512-7523. PubMed ID: 36290868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI.
    Phan TT; Ho TT; Nguyen HT; Nguyen HT; Tran TB; Nguyen ST
    Int J Gen Med; 2018; 11():423-430. PubMed ID: 30510441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.
    Li YX; Chang JY; He MY; Wang HR; Luo DQ; Li FH; Li JH; Ran L
    J Oncol; 2021; 2021():2939162. PubMed ID: 34539781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab.
    Sánchez-Gastaldo A; Muñoz-Fuentes MA; Molina-Pinelo S; Alonso-García M; Boyero L; Bernabé-Caro R
    Transl Lung Cancer Res; 2021 Jun; 10(6):2509-2522. PubMed ID: 34295658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
    Solmaz S; Uzun O; Acar C; Sevindik OG; Piskin O; Ozsan HG; Demirkan F; Undar B; Alacacioglu A; Ozcan MA; Alacacioglu I
    J Lab Physicians; 2018; 10(4):363-369. PubMed ID: 30498304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
    Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.